SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-13-304290
Filing Date
2013-07-26
Accepted
2013-07-26 13:12:02
Documents
5

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO FORM F-1 d517182df1a.htm F-1/A 73258
2 EX-1.1 d517182dex11.htm EX-1.1 232051
3 EX-4.1 d517182dex41.htm EX-4.1 3417
4 GRAPHIC g517182img1.jpg GRAPHIC 436311
5 GRAPHIC g517182img2.jpg GRAPHIC 96730
  Complete submission text file 0001193125-13-304290.txt   1044432
Mailing Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112
Business Address ONE KEW PLACE 150 ROUSE BOULEVARD PHILADELPHIA PA 19112 267-546-3003
Iroko Pharmaceuticals Inc. (Filer) CIK: 0001566717 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-189428 | Film No.: 13988809
SIC: 2834 Pharmaceutical Preparations